Skip to main content
Caplight Logo









Delsona Therapeutics

Delsona Therapeutics

Private
New York City, New YorkHealthcare & Life Scienceshttps://delsona.com/

Last Round

Accelerator

Dec 14, 2023

Company Overview

Delsona Therapeutics is a clinical-stage therapeutics company developing a drug delivery platform, called UltraNav, which uses focused ultrasound to non-invasively open the blood-brain barrier for treating life-threatening diseases of the brain.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Revenue Share, Usage-Based SaaS

AI Layer

Non-AI

Keywords

focused ultrasoundblood-brain barrier openingdrug delivery platformFUSbrain drug deliverymedical deviceMedTechblood-brain barrierBBBclinical-stage companyneuronavigationpediatric brain cancerAlzheimer's diseasemicrobubble-enhanced ultrasoundneurodegenerative diseasebiotechnologycentral nervous system diseasesCNS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Delsona Therapeutics Comparables

Compare Delsona Therapeutics with similar companies based on industry and business-model similarity.

Delsona Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cordance Medical
84%
NaviFUS Corp.
82%
Ceretas
82%

Delsona Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorDec 14, 2023

Delsona Therapeutics Investors

Notable investors and investment history

Delsona Therapeutics investors
InvestorRounds
Westchester County Biosciences AcceleratorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 14, 2023

    Received funding from Westchester County Biosciences Accelerator.

Delsona Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Delsona Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Delsona Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Year FoundedN/A
Last FundingDec 14, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?